How many 6-K filings has Inventiva S.A. filed?

Inventiva S.A. (IVEVF) has 50 6-K (Foreign Current Report) filings on record, spanning Feb 2024 to Nov 2025.

What is a 6-K filing?

A 6-K is an SEC filing known as "Foreign Current Report." Current report filed by foreign private issuers for material events. Equivalent to the 8-K for domestic companies.

Where can I read Inventiva S.A. 6-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Inventiva S.A. 6-K filings, including risk assessment, sentiment analysis, and key financial figures.

Inventiva S.A. (IVEVF) — 6-K Filings

All 6-K filings from Inventiva S.A.. Browse 50 Foreign Current Report reports with AI-powered summaries and risk analysis.

6-K Filings (50)

6-K Filing — Nov 28, 2025
6-K Filing — Nov 24, 2025
Inventiva S.A. Files November 2025 Form 6-K — Nov 17, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on November 17, 2025, to report information for the month of November 2025. The company, a foreign private issuer, is incorporat
Inventiva S.A. Announces Public Offering of ADSs — Nov 13, 2025 Risk: medium
On November 12, 2025, Inventiva S.A. entered into an Underwriting Agreement with Leerink Partners LLC and Piper Sandler & Co. for a public offering of 38,961,03
6-K Filing — Nov 7, 2025
6-K Filing — Nov 6, 2025
Inventiva S.A. Distributes Proxy Cards for Shareholder Meeting — Oct 30, 2025 Risk: low
On October 30, 2025, Inventiva S.A. began distributing proxy cards for its upcoming Extraordinary General Meeting of Shareholders. The meeting is scheduled to a
Inventiva S.A. Files 6-K for Annual General Meeting — Oct 20, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on October 20, 2025, to announce its Annual General Meeting. The filing is a report of a foreign private issuer and is being fur
Inventiva S.A. Files Form 6-K with Press Release and Financial Report — Oct 14, 2025 Risk: low
On October 14, 2025, Inventiva S.A. (Nasdaq: IVA) issued a press release and made available management's interim financial report. The filing does not contain s
Inventiva S.A. Files October 2025 6-K Report — Oct 1, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on October 1, 2025, reporting its activities for the month of October 2025. The company, a pharmaceutical preparations firm, is
Inventiva S.A. Files H1 2025 Financials and Corporate Update — Sep 29, 2025 Risk: low
On September 29, 2025, Inventiva S.A. filed its Interim Financial Report for the six months ended June 30, 2025. The company also issued a press release on the
Inventiva S.A. Files July 2025 6-K Report — Jul 29, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on July 29, 2025, to report information for the month of July 2025. The company, a pharmaceutical preparations firm, is based in
Inventiva S.A. Files July 2025 6-K Report — Jul 9, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on July 9, 2025, to report its activities for the month of July 2025. The company, a pharmaceutical preparations firm, is based
Inventiva S.A. Files July 2025 6-K Report — Jul 7, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on July 7, 2025, to report its activities for the month of July 2025. The company, a foreign private issuer, is incorporated in
Inventiva S.A. Files Form 6-K — May 23, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on May 23, 2025, reporting as a foreign private issuer. The company, incorporated in France with its principal executive offices
Inventiva S.A. Files May 2025 Report (6-K) — May 22, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on May 22, 2025, to report its activities for the month of May 2025. The company, incorporated in France, is a pharmaceutical pr
Inventiva S.A. Files 6-K on Subscription Agreements — May 5, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on May 5, 2025, to report on the entry into subscription agreements with certain investors. These agreements, previously disclos
Inventiva S.A. Announces Annual General Meeting Notice — May 2, 2025 Risk: low
Inventiva S.A. published a notice of meeting on May 2, 2025, for its Annual General Meeting. The company is a foreign private issuer incorporated in France and
Inventiva S.A. Files April 2025 6-K Report — Apr 30, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on April 30, 2025, reporting its activities for the month of April 2025. The company, a pharmaceutical preparations firm, is bas
Inventiva S.A. mails proxy card for May 22 General Meeting — Apr 24, 2025 Risk: low
Inventiva S.A. announced on April 24, 2025, that it has begun mailing its proxy card for its Ordinary and Extraordinary General Meeting. This meeting is schedul
Inventiva S.A. Announces Annual General Meeting Notice — Apr 11, 2025 Risk: low
Inventiva S.A. published a notice of meeting on April 11, 2025, for its Annual General Meeting. The company is a foreign private issuer incorporated in France a
Inventiva S.A. Files Routine 6-K Report — Apr 1, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on April 1, 2025, reporting for the month of April 2025. The company, a pharmaceutical preparations firm, is based in Daix, Fran
Inventiva S.A. Files March 2025 6-K Report — Mar 26, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on March 26, 2025, to report its activities for the month of March 2025. The company, a pharmaceutical preparations firm, is bas
Inventiva S.A. Files Form 6-K for February 2025 — Feb 20, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on February 20, 2025, to report information for the month of February 2025. The company, incorporated in France with its princip
Inventiva S.A. Files February 2025 6-K Report — Feb 10, 2025 Risk: low
Inventiva S.A. filed a Form 6-K on February 10, 2025, to report for the month of February 2025. The company, incorporated in France, is in the pharmaceutical pr
Inventiva S.A. Reports on Subscription Agreements — Dec 16, 2024 Risk: low
Inventiva S.A. is filing a Form 6-K for December 2024, reporting on the entry into subscription agreements with certain investors. These agreements, previously
Inventiva S.A. Files Form 6-K — Dec 12, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on December 12, 2024, to report information for the month of December 2024. The company, incorporated in France with its princip
Inventiva S.A. Files 6-K for November 2024 Meeting — Nov 26, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on November 26, 2024, reporting on its Ordinary and Extraordinary General Meeting held on November 22, 2024. The filing is for t
Inventiva S.A. Files November 2024 6-K Report — Nov 21, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on November 21, 2024, to report information for the month of November 2024. The company, a pharmaceutical preparations firm, is
Inventiva S.A. Files November 2024 Report (6-K) — Nov 20, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on November 20, 2024, to report its activities for the month of November 2024. The company, a pharmaceutical preparations firm,
Inventiva S.A. Files 6-K, Confirms 20-F Reporting — Nov 15, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on November 15, 2024, to report information as a foreign private issuer. The filing indicates that the company is submitting its
Inventiva S.A. mails proxy card for Dec 11 General Meeting — Nov 14, 2024 Risk: low
Inventiva S.A. announced on November 14, 2024, that it is mailing its proxy card for its Ordinary and Extraordinary General Meeting scheduled for December 11, 2
Inventiva S.A. Announces Annual General Meeting Notice — Nov 4, 2024 Risk: low
Inventiva S.A. announced on November 4, 2024, that it published a notice regarding its upcoming Annual General Meeting. The filing does not contain specific fin
Inventiva S.A. Files October 2024 6-K Report — Oct 30, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on October 30, 2024, to report its activities for the month of October 2024. The company, incorporated in France and operating i
Inventiva S.A. Announces Share Subscription Agreements — Oct 15, 2024 Risk: medium
On October 11, 2024, Inventiva S.A. entered into subscription agreements with certain investors to issue and sell ordinary shares or pre-funded warrants. This a
Inventiva S.A. Files September 2024 6-K Report — Sep 25, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on September 25, 2024, to report information for the month of September 2024. The company, a foreign private issuer, is based in
Inventiva S.A. Files July 2024 Report (6-K) — Jul 31, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on July 31, 2024, to report its activities for the month of July 2024. The company, incorporated in France and operating in the
Inventiva S.A. Issues 201 Royalty Certificates to Investors — Jul 18, 2024 Risk: medium
On July 17, 2024, Inventiva S.A. entered into Royalty Certificate Subscription Agreements to issue and sell 201 royalty certificates to certain investors. This
Inventiva S.A. Files July 2024 Report (6-K) — Jul 5, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on July 5, 2024, to report its activities for the month of July 2024. The company, incorporated in France, is a pharmaceutical p
Inventiva S.A. Files June 2024 Report (6-K) — Jun 21, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on June 21, 2024, to report for the month of June 2024. The company, incorporated in France, is in the pharmaceutical preparatio
Inventiva S.A. Announces Annual General Meeting Details — Jun 5, 2024 Risk: low
Inventiva S.A. announced on June 3, 2024, that it will hold its Annual General Meeting on June 27, 2024. Shareholders will vote on the approval of the company's
Inventiva S.A. Files May 2024 Report (6-K) — May 30, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on May 30, 2024, to report its activities for the month of May 2024. The company, based in Daix, France, is a pharmaceutical pre
Inventiva S.A. Files May 2024 Report on Form 6-K — May 21, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on May 21, 2024, to report its activities for the month of May 2024. The company, a pharmaceutical preparations firm, is based i
Inventiva S.A. Files May 2024 Report (6-K) — May 16, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on May 16, 2024, to report its activities for the month of May 2024. The company is a foreign private issuer and is required to
Inventiva S.A. Files Form 6-K — May 13, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on May 13, 2024, reporting as a foreign private issuer. The company is incorporated in France and its principal executive office
Inventiva S.A. Announces 2024 Annual General Meeting Details — May 13, 2024 Risk: low
On May 13, 2024, Inventiva S.A. (NASDAQ: IVA) announced its Annual General Meeting (AGM) will be held on June 20, 2024. Shareholders will vote on key proposals,
Inventiva S.A. Files March 2024 Report (6-K) — Mar 27, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on March 27, 2024, to report for the month of March 2024. The company, incorporated in France, is a foreign private issuer and f
Inventiva S.A. Files March 2024 Report on Form 6-K — Mar 18, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on March 18, 2024, to report its activities for the month of March 2024. The company, incorporated in France and operating in th
Inventiva S.A. Files Form 6-K — Mar 7, 2024 Risk: low
Inventiva S.A. filed a Form 6-K on March 7, 2024, to report its status as a foreign private issuer filing annual reports under Form 20-F. The filing provides ba
Inventiva S.A. Files Routine February 2024 6-K with SEC — Feb 15, 2024 Risk: low
Inventiva S.A. submitted a routine Form 6-K to the SEC for the month of February 2024, as a foreign private issuer. The filing, dated February 15, 2024, include

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX